Browse the latest SEC filings and forms submitted by Neumora Therapeutics, Inc. (NMRA). Access annual reports, quarterly statements, and other official disclosures.
View Insider Transactions for Neumora Therapeutics, Inc. (NMRA).
Search Company Filings →| Form | Filing Date | Description | Link |
|---|---|---|---|
| 8-K | March 30, 2026 | 8-K | View Document |
| S-8 | March 30, 2026 | S-8 | View Document |
| 10-K | March 30, 2026 | 10-K | View Document |
| SCHEDULE 13G | Feb. 19, 2026 | - | View Document |
| 4 | Feb. 19, 2026 | - | View Document |
| 4 | Feb. 19, 2026 | - | View Document |
| 4 | Feb. 19, 2026 | - | View Document |
| 4 | Feb. 19, 2026 | - | View Document |
| 144 | Feb. 17, 2026 | - | View Document |
| SCHEDULE 13G/A | Feb. 17, 2026 | - | View Document |
| 144 | Feb. 17, 2026 | - | View Document |
| 144 | Feb. 17, 2026 | - | View Document |
| 144 | Feb. 17, 2026 | - | View Document |
| 8-K | Feb. 11, 2026 | 8-K | View Document |
| 8-K | Jan. 12, 2026 | 8-K | View Document |
| 4 | Jan. 9, 2026 | - | View Document |
| 4 | Jan. 9, 2026 | - | View Document |
| 4 | Jan. 9, 2026 | - | View Document |
| 4 | Jan. 9, 2026 | - | View Document |
| 4 | Jan. 9, 2026 | - | View Document |
| 8-K | Jan. 5, 2026 | 8-K | View Document |
| 8-K | Nov. 21, 2025 | 8-K | View Document |
| 4 | Nov. 13, 2025 | - | View Document |
| 144 | Nov. 12, 2025 | - | View Document |
| 8-K | Nov. 6, 2025 | 8-K | View Document |
| 10-Q | Nov. 6, 2025 | 10-Q | View Document |
| 4 | Oct. 29, 2025 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Oct. 29, 2025 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Oct. 29, 2025 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| SCHEDULE 13D/A | Oct. 29, 2025 | - | View Document |
| 8-K | Oct. 27, 2025 | 8-K | View Document |
| 8-K | Oct. 27, 2025 | 8-K | View Document |
| SCHEDULE 13G | Aug. 11, 2025 | - | View Document |
| 8-K | Aug. 6, 2025 | 8-K | View Document |
| 10-Q | Aug. 6, 2025 | 10-Q | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 8-K | May 30, 2025 | 8-K | View Document |
| 4 | May 30, 2025 | 4 | View Document |
| 4 | May 23, 2025 | - | View Document |
| 8-K | May 16, 2025 | 8-K | View Document |
| DEFA14A | May 16, 2025 | DEFA14A | View Document |
| 10-Q | May 12, 2025 | 10-Q | View Document |
| SCHEDULE 13G/A | May 12, 2025 | - | View Document |
| 8-K | May 12, 2025 | 8-K | View Document |
| DEF 14A | April 29, 2025 | DEF 14A | View Document |
| DEFA14A | April 29, 2025 | DEFA14A | View Document |
| 8-K/A | April 11, 2025 | 8-K/A | View Document |
| PRE 14A | April 11, 2025 | PRE 14A | View Document |
| EFFECT | March 26, 2025 | - | View Document |
| 144 | March 12, 2025 | - | View Document |
| S-8 | March 3, 2025 | S-8 | View Document |
| 10-K | March 3, 2025 | 10-K | View Document |
| POSASR | March 3, 2025 | POSASR | View Document |
| 8-K | March 3, 2025 | 8-K | View Document |
| POS AM | March 3, 2025 | POS AM | View Document |
| 8-K/A | Feb. 21, 2025 | 8-K/A | View Document |
| 4 | Feb. 20, 2025 | - | View Document |
| 4 | Feb. 20, 2025 | - | View Document |
| 4 | Feb. 20, 2025 | - | View Document |
| 4 | Feb. 20, 2025 | - | View Document |
| 4 | Feb. 20, 2025 | - | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 4 | Feb. 18, 2025 | 4 | View Document |
| 8-K | Feb. 13, 2025 | 8-K | View Document |
| SCHEDULE 13G/A | Feb. 13, 2025 | - | View Document |
| 8-K | Jan. 13, 2025 | 8-K | View Document |
| 8-K | Jan. 2, 2025 | 8-K | View Document |
| 4 | Dec. 27, 2024 | - | View Document |
| SC 13D/A | Nov. 22, 2024 | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#2) | View Document |
| 10-Q | Nov. 12, 2024 | 10-Q | View Document |
| SC 13G | Nov. 12, 2024 | - | View Document |
| 8-K | Nov. 12, 2024 | 8-K | View Document |
| 4 | Oct. 18, 2024 | - | View Document |
| 144 | Oct. 18, 2024 | - | View Document |
| 144 | Oct. 17, 2024 | - | View Document |
| 4 | Oct. 11, 2024 | - | View Document |
| 144 | Oct. 10, 2024 | - | View Document |
| 144 | Oct. 9, 2024 | - | View Document |
| S-3ASR | Oct. 1, 2024 | S-3ASR | View Document |
| 4 | Sept. 19, 2024 | - | View Document |
| 144 | Sept. 18, 2024 | - | View Document |
| 144 | Sept. 17, 2024 | - | View Document |
| 4 | Sept. 16, 2024 | - | View Document |
| 4 | Sept. 13, 2024 | - | View Document |
| 144 | Sept. 12, 2024 | - | View Document |
| 4 | Aug. 27, 2024 | - | View Document |
| 4 | Aug. 26, 2024 | - | View Document |
| 144 | Aug. 22, 2024 | - | View Document |
| 8-K | Aug. 6, 2024 | 8-K | View Document |
| 10-Q | Aug. 6, 2024 | 10-Q | View Document |
| SCHEDULE 13G | July 8, 2024 | - | View Document |
| SCHEDULE 13G | July 8, 2024 | - | View Document |
| 4 | June 28, 2024 | - | View Document |
| 4 | June 14, 2024 | - | View Document |
| 4 | June 14, 2024 | - | View Document |
| 4 | June 14, 2024 | - | View Document |
| 4 | June 14, 2024 | - | View Document |
| 4 | June 14, 2024 | - | View Document |
| 8-K | June 14, 2024 | 8-K | View Document |
| 10-Q | May 7, 2024 | 10-Q | View Document |
| 8-K | May 7, 2024 | 8-K | View Document |
| DEF 14A | April 25, 2024 | DEF 14A | View Document |
| DEFA14A | April 25, 2024 | DEFA14A | View Document |
| 4 | April 24, 2024 | - | View Document |
| 8-K | April 15, 2024 | 8-K | View Document |
| S-8 | March 7, 2024 | S-8 | View Document |
| 8-K | March 7, 2024 | 8-K | View Document |
| 10-K | March 7, 2024 | 10-K | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| 4 | Feb. 16, 2024 | - | View Document |
| SC 13G | Feb. 14, 2024 | SC 13G | View Document |
| SC 13G | Feb. 13, 2024 | - | View Document |
| 8-K | Jan. 8, 2024 | 8-K | View Document |
| SC 13D/A | Dec. 15, 2023 | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1) | View Document |
| 4 | Dec. 12, 2023 | - | View Document |
| 4 | Dec. 12, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Dec. 12, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 3 | Dec. 12, 2023 | - | View Document |
| 4 | Dec. 12, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 8-K | Nov. 28, 2023 | 8-K | View Document |
| 4 | Nov. 15, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Nov. 15, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Nov. 13, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Nov. 13, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Nov. 7, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Nov. 7, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 10-Q | Nov. 1, 2023 | 10-Q | View Document |
| 8-K | Nov. 1, 2023 | 8-K | View Document |
| SC 13D | Oct. 2, 2023 | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D | View Document |
| 4 | Sept. 29, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Sept. 29, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Sept. 27, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| SC 13D | Sept. 27, 2023 | SC 13D | View Document |
| 4 | Sept. 27, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Sept. 25, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Sept. 25, 2023 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 4 | Sept. 21, 2023 | FORM 4 SUBMISSION | View Document |
| 4 | Sept. 20, 2023 | FORM 4 SUBMISSION | View Document |
| 4 | Sept. 20, 2023 | - | View Document |
| 4 | Sept. 20, 2023 | FORM 4 SUBMISSION | View Document |
| S-8 | Sept. 20, 2023 | S-8 | View Document |
| 4 | Sept. 19, 2023 | - | View Document |
| 4 | Sept. 19, 2023 | - | View Document |
| 8-K | Sept. 19, 2023 | 8-K | View Document |
| 3 | Sept. 18, 2023 | FORM 3 SUBMISSION | View Document |
| 424B4 | Sept. 18, 2023 | 424B4 | View Document |
| 4 | Sept. 18, 2023 | - | View Document |
| 4 | Sept. 18, 2023 | - | View Document |
| 4 | Sept. 18, 2023 | - | View Document |
| 4 | Sept. 18, 2023 | - | View Document |
| 4 | Sept. 18, 2023 | - | View Document |
| 4 | Sept. 18, 2023 | - | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| CERT | Sept. 14, 2023 | - | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| SEC STAFF LETTER | Sept. 14, 2023 | - | View Document |
| EFFECT | Sept. 14, 2023 | - | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 3 | Sept. 14, 2023 | FORM 3 SUBMISSION | View Document |
| 8-A12B | Sept. 13, 2023 | 8-A12B | View Document |
| CORRESP | Sept. 12, 2023 | - | View Document |
| CORRESP | Sept. 12, 2023 | - | View Document |
| S-1/A | Sept. 11, 2023 | S-1/A | View Document |
| CORRESP | Aug. 25, 2023 | - | View Document |
| S-1 | Aug. 25, 2023 | S-1 | View Document |
| UPLOAD | Aug. 17, 2023 | - | View Document |
| DRS/A | Aug. 9, 2023 | - | View Document |
| DRSLTR | Aug. 8, 2023 | - | View Document |
| UPLOAD | July 12, 2023 | - | View Document |
| DRSLTR | June 30, 2023 | - | View Document |
| DRS/A | June 30, 2023 | - | View Document |
| SEC STAFF LETTER | May 24, 2023 | - | View Document |
| UPLOAD | May 24, 2023 | - | View Document |
| DRS/A | May 2, 2023 | - | View Document |
| D | Jan. 3, 2023 | - | View Document |
| DRSLTR | Sept. 2, 2022 | - | View Document |
| DRS/A | Sept. 2, 2022 | - | View Document |
| UPLOAD | June 17, 2022 | - | View Document |
| DRS/A | June 10, 2022 | - | View Document |
| DRSLTR | June 10, 2022 | - | View Document |
| UPLOAD | May 16, 2022 | - | View Document |
| DRS/A | May 2, 2022 | - | View Document |
| DRS/A | Feb. 14, 2022 | - | View Document |
| DRSLTR | Feb. 11, 2022 | - | View Document |
| UPLOAD | Jan. 7, 2022 | - | View Document |
| DRS/A | Dec. 23, 2021 | - | View Document |
| DRSLTR | Dec. 22, 2021 | - | View Document |
| UPLOAD | Dec. 6, 2021 | - | View Document |
| DRS | Nov. 8, 2021 | - | View Document |